Showing 1 to 1 of 1 results
dailymail.co.uk
🌐 85% Global Worthiness
NHS to Decide on Alzheimer's Drug HMTM by April
The UK's National Health Service (NHS) is evaluating hydromethylthionine mesylate (HMTM), an oral drug, for treating Alzheimer's disease; early trials show promise in slowing disease progression, with a decision expected by April.
NHS to Decide on Alzheimer's Drug HMTM by April
The UK's National Health Service (NHS) is evaluating hydromethylthionine mesylate (HMTM), an oral drug, for treating Alzheimer's disease; early trials show promise in slowing disease progression, with a decision expected by April.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results